You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《滬深兩市》金融股力撐上證全日靠穩 創板跌2.2% CRO概念股急挫
人民銀行今日進行4,610億元七天期逆回購操作,中標利率持平於1.8%。今日單日淨投放3,900億元。人民幣兌美元中間價今下調30點,報7.1074。A股三大指數連升三日後今早低開低走,其後個別發展,券商股力撐上證靠穩,創板回吐大跌超過2%。 滬指全日收報2,910點,升4點或0.1%,成交額4,024億元。深成指收報8,762點,跌93點或1.1%,成交額4,263億元。創業板收報1,682點,跌38點或2.2%,成交額1,705億元。 中資金融股支撐上證指數,建行(601939.SH)及工行(601398.SH)分別升2.1%及1.6%。個別券商股偏好,華鑫股份(600621.SH)、中國銀河(601881.SH)及哈投股份(600864.SH)升1.7%至2.9%。 國務院國資委將進一步研究將市值管理納入中央企業負責人業績考核,加大現金分紅力度。個別中字頭概念股續升,中鋁國際(601068.SH)及中視傳媒(600088.SH)再漲停。中石油(601857.SH)及中海油(600938.SH)分別揚6.4%及2.5%。 龍頭內房股持續向好,萬科(000002.SZ)、金地集團(600383.SH)及保利發展(600048.SH)升2.4%至4.9%。住建部表示,將建立城市房地產融資協調機制項目信息平台,首批名單加快落地。 內地本月有115款國產網絡遊戲獲批版號,遊戲股走高,中青寶(300052.SZ)漲16.5%。盛天網絡(300494.SZ)揚6%。 傳美中特別委員會提議禁止華大基因(300676.SZ)及藥明康德(603259.SH)等外國生物公司,華大基因跌3%。藥明康德跌停。其他CRO概念股快速跟挫,美迪西(688202.SH)、康龍化成(300759.SZ)、泰格醫藥(300347.SZ)挫6.5%至12.9%。 比亞迪(002594.SZ)及寧德時代(300750.SZ)分別跌2.1%及3.2%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account